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Abstract 
Background: Methyltransferases (MTs) catalyze the S-adenosylmethionine (SAM)-dependent methylation of a 
wide variety of protein and DNA substrates. Methylation of lysine, arginine or cytosine regulates a variety of biologi-
cal processes including transcriptional activation and gene silencing. Despite extensive studies of the cellular roles 
of MTs, their quantitative kinetic characterization remains challenging. In the past decade, several assays have been 
developed to monitor methyl transfer activity utilizing different approaches including radiolabeling, antibodies or 
mass-spectrometry analysis. However, each approach suffers from different limitation and no easy continuous assay 
for detection of MT activity exists.
Results: We have developed a continuous coupled assay for the general detection of MTs activity. In this assay, the 
formation of S-adenosylhomocysteine (SAH) product is coupled NAD(P)H oxidation through three enzyme reactions 
including glutamate dehydrogenase leading to absorbance changes at 340 nm. The utility and versatility of this assay 
is demonstrated for SET7/9 and SETD6 with peptides and full length protein substrates and for M.HaeIII with a DNA 
substrate.
Conclusions: This study shows a simple and robust assay for the continuous monitoring of MT enzymatic activity. 
This assay can be used for the determination of steady-state kinetic enzymatic parameters (e.g., kcat and KM) for a wide 
variety of MTs and can be easily adapted for high-throughput detection of MT activity for various applications.
© 2015 Duchin et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Methylation is a common covalent modification of 
nucleic acids and proteins. Recently, methylation has 
emerged as a prominent posttranslational modification 
of proteins regulating diverse cellular signaling pathways 
that influence cell survival, growth, and proliferation. 
Disruption of methylation is thought to fundamentally 
impact the initiation and progression of many biologi-
cal processes, leading to altered cellular phenotypes and 
the development of diseases [1–4]. Methylation of lysine 
residues in target proteins is performed by protein lysine 
(K) methyltransferases (PKMTs) [5, 6]. Currently, there 
are over 60 candidates and known members of this 
enzyme family, the vast majority of which contain a con-
served SET domain that is responsible for the enzymatic 
activity [5, 6]. Methylation also takes place on genomic 
DNA on cytosine bases in CpG dinucleotide repeats [7]. 
These regions of the genome are enriched in transcrip-
tionally repressed chromatin and methylation mediates 
epigenetic silencing within these domains [8]. Thus, DNA 
methylation was shown to play a crucial role in the epige-
netic control of gene expression [9].
All methyltransferases (MTs) utilize the S-adenosyl-
methionine (SAM) as a universal methyl donor leading 
to the generation of S-adenosylhomocysteine (SAH) fol-
lowing methylation. Due to the central biological roles 
of MTs, it is important to biochemically characterize 
and quantitatively measure their catalytic activity. Previ-
ous efforts for the development of quantitative assays for 
MTs activity rely on the detection of methylated prod-
uct or the formation of SAH [10, 11]. Radioactive assays 
utilizing 3H-SAM are considered the most sensitive and 
reliable but require chromatographic separation and thus 
tend to be slow and labor intensive [12]. Recently, more 
advanced and rapid radioactive assays were developed 
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to allow the detection of many MTs reactions in parallel 
[13–16]. More recently, fluorescent [17], antibody-based 
immunoassays or reading domain-based assays [18–20] 
for the detection of methylated lysine, arginine and cyto-
sine were developed utilizing enzyme-linked immuno-
sorbent assay (ELISA) or fluorescence resonance energy 
transfer (FRET) [21–23]. These assays based on fluo-
rescence or absorbance are highly sensitive but are not 
general for the detection of a wide range of MT activi-
ties because a specific antibody for each substrate and/or 
type of modification must be used.
Assays for the detection of SAH [24–26] have the 
advantage of providing a general detection method 
for MTs regardless of the protein or DNA acceptor. 
Previously, the accumulation of SAH product at high 
concentration was shown to inhibit most MTs activity 
[27, 28]. The coupled assay can overcome this problem 
by preventing the accumulation of the SAH following 
MTs activity. Several coupled enzyme assays have been 
developed for SAH detection including the conver-
sion of SAH to adenosine and homocysteine enabling 
the colorimetric or fluorescent detection with thiol 
reactive chromophores or fluorophores, respectively 
[26, 28, 29]. However, these assays were not utilized 
in a continuous manner due to possible interference 
from protein cysteine residues and the presence of 
thiol reducing reagents. An alternative approach uti-
lizes SAH nucleosidase (SAHN) [30] to generate ade-
nine and S-ribosylhomocysteine followed by adenine 
deaminase (ADE) to generate hypoxanthine [24]. This 
reaction can be followed continuously at 265 nm; how-
ever, due to the high absorbance of proteins at 280 nm, 
this approach is difficult to apply for MTs detection. 
An extension of this assay that includes xanthine oxi-
dase for the generation of fluorogenic xanthine deriva-
tives was commercialized but still suffers from limited 
dynamic range.
Here, we report the establishment of a coupled con-
tinuous assay for MTs that is based on monitoring SAH 
formation during the MT reaction. We have utilized 
SAHN, ADE and glutamate dehydrogenase [31] to cou-
ple enzymatic MT activity to NADPH oxidation (Fig. 1). 
NADPH oxidation is then followed at 340  nm allowing 
a convenient and robust detection of MT activity using 
standard cuvettes or multi-well plate format. Since meth-
ylation is the rate-limiting step in the coupled assay (see 
below), the rate of NADPH oxidation reflects the rate of 
methylation. We have shown that this assay is highly ver-
satile allowing the quantitative detection of MTs activity 
toward peptide or protein substrates and for the detec-
tion of DNA MTs activity. This coupled assay permits 
the Michaelis–Menten (MM) analysis of MTs catalytic 
activity for mechanistic studies and is readily adaptable 
for high-throughput screening for the discovery of novel 
MTs inhibitors.
Results
Development of a coupled continuous assay for MTs
To establish a continuous assay for MTs activity that 
monitors SAH formation, the transfer of a methyl group 
to peptide, protein or DNA must be coupled to additional 
reactions that lead to measurable change in absorbance/
fluorescence. Previous work has utilized SAHN and ADE 
for the conversion of SAH to hypoxanthine and ammo-
nia [24]. These two coupled reactions were shown to 
be non-rate limiting enabling the efficient coupling of 
methyl transfer reaction to hypoxanthine formation that 
is monitored at 265  nm [24]. However, measuring MTs 
activity at 265 nm is highly problematic due to the high 
absorbance of proteins at 280 nm and the inability to uti-
lize standard cuvettes or multi-well plates due to their 
high absorbance at this wavelength. To overcome these 
limitations, we have coupled the activity of SAHN and 
ADE with glutamate dehydrogenase that utilizes ammo-
nia and α-ketoglutarate to generate glutamate while oxi-
dizing NADPH. The coupling of this reaction to MTs 
activity allows monitoring the continuous change in 
absorbance at 340 nm due to NADPH oxidation (Fig. 1) 
which linearly correlates with the reduction of the SAM 
concentration.
To establish the continuous coupled assay for MTs 
activity, we initially utilized the PKMTs SET7/9 as a model 
enzyme. Previous works have shown that SET7/9 exhibits 
broad substrate specificity catalyzing methyl transfer to a 
variety of histone and non-histone proteins including H3, 
TAF10, TAT, RelA, p53 and FoxO3 [5, 32]. Methylation of 
these proteins by SET7/9 was shown to regulate protein–
protein and protein–DNA interactions thus modulating 
the target protein activity [5, 33]. We initially utilized 
our coupled assay to monitor SET7/9 activity with a pep-
tide substrate derived from the HIV trans-activator TAT 
protein. SET7/9 was previously shown to monomethyl-
ate TAT protein at K51, thus, a peptide was designed to 
include the K51 acceptor residue (see peptide sequence 
in the “Methods” section). We found that when all com-
ponents of the coupled reaction are present, a gradual 
change in absorbance at 340 nm was observed indicating 
the successful coupling of SET7/9 activity with NADPH 
oxidation (Fig. 2a). To verify that our coupled assay spe-
cifically measures MT activity, we performed several 
control reactions in which one of the reaction compo-
nents was omitted. We observed that when each of the 
coupled enzymes or SAM was absent from the reaction 
mix no activity was measured (Fig. 2a; Additional file 1: 
Figure S1). In addition, we observed that in the pres-
ence of SET7/9 variant containing the E254A mutation, 
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very low activity was observed in accordance with previ-
ous report [34] (Fig. 2a). To further verify that SET7/9 is 
the rate-determining step in our kinetic measurements, 
we examined the catalytic rate of each step in the cou-
pled reaction independently by monitoring NADPH 
oxidation. We found that under our reaction mixture 
(see “Methods” for details) the three coupling enzymes 
are significantly faster than SET7/9 activity (Fig.  2b). 
We have also shown that increasing in SET7/9 enzyme 
concentration is directly proportional to the increase in 
catalytic activity (Fig. 2c). To further verify that the MT 
reaction is the rate-determining step, we performed the 
Fig. 1 General diagram for the continuous coupled assay for MTs activity. a In this assay, MTs activity is coupled to three enzymes: SAH nucleosi-
dase (SAHN), adenine deaminase (ADE) and glutamate dehydrogenase to couple methyl transfer activity to NADPH oxidation. As a result, methyl 
transfer activity is directly monitored by a decrease in absorbance at 340 nm. b Diagram describing the chemical structure of SAM, SAH and all 
other products derived from the activity of the three coupled enzyme
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reaction with doubled amount of each of the coupling 
enzymes (ADE, SAHN and glutamate dehydrogenase) 
and observed no increase in methylation rate (Additional 
file  1: Figure S2). Next, we examined the sensitivity of 
our assay by determining NADPH oxidation at limited 
SAH concentrations. Using this assay, we were able to 
detect a concentration of 170  nM of SAH highlighting 
that a transfer of 170 nM of methyl group to a peptide/
protein substrate is detectable in our system (Additional 
file 1: Figure S3). Overall, these controls ensure that the 
change in absorbance at 340 nm reflects the true meas-
urement of SET7/9 methylation activity and provides a 
wide dynamic range for activity measurements at differ-
ent conditions (e.g., substrate concentrations see below).
Measurements of SET7/9 and SETD6 activity with peptide 
and protein substrates
To examine whether our coupled kinetic assay can be 
utilized for the MM kinetic analysis of SET7/9 activity, 
we have utilized a peptide derived from the FoxO3 pro-
tein. Previous work has shown that SET7/9 methylates 
FoxO3 at K271 modulating its transcriptional activity 
and stability [35]. Thus, we have designed a 15 amino acid 
peptide substrate derived from FoxO3 containing K271 
to quantitatively measure SET7/9 catalytic activity (see 
peptide sequence in the “Methods” section). Using the 
coupled assay, we measured the initial rates of SET7/9 
activity (5 μM) at different peptide substrate concentra-
tions ranging from 0 to 700 μM (Fig. 3a). As expected, we 
observed a gradual increase in initial rates that is corre-
lated with the increase in FoxO3 peptide concentration. 
Fitting the initial rate data to the MM equation allowed 
us to derive kinetic parameters for the activity of SET7/9 
with the FoxO3 peptide (Fig. 3b). We found that the KM 
and kcat parameters for this activity are 165.4 ± 20.2 μM 
and 32  ±  0.023  min−1, respectively. The values are in 
excellent correlation with previous analysis of SET7/9 
activity with H3K4 and DNMT1K142 utilizing radioac-
tive MT assay [36]. The previously measured KM and Kcat 
for H3K4 and DNMTK142 are 143 and 134 μM and 48 
and 42 min−1, respectively [36]. This correlation provides 
strong support for our continuous assay and confirms 
that the FoxO3 peptide is a substrate for SET7/9 [35].
Fig. 2 Establishment of the continuous coupled assay for MTs 
using short peptide as a substrate a. The detection of MTs activity is 
dependent on all assay components. The reaction cannot be moni-
tored in the absence of SAM (orange), SAHN (grey), ADE or glutamate 
dehydrogenase (Additional file 1: Figure S1). In addition, very low 
activity was monitored in the presence of SET7/9 inactive mutant 
(yellow). Activity is measured only when all reaction components are 
present including the peptide substrate (TAT peptide as an example, 
blue). b SET7/9 activity is the rate-limiting step in the three enzyme 
coupled assay. Each enzyme was monitored separately to ensure 
the determination of SET7/9 activity. Absorbance values at 340 nm 
in all reactions are normalized to 1 and the change in absorbance 
over time is presented as 1—the absorbance value obtains for each 
measurement. For represented raw data of absorbance change at 
340 nm please see Additional file 1: Figure S4. c SET7/9 activity with 
TAT peptide (500 μM) at increasing enzyme concentrations including 
1, 3, 6 μM leads to a proportional increase in reaction rate highlight-
ing that this is the rate-determining step for the coupled assay
◂
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To further examine whether the coupled assay can 
monitor MTs activity with full length protein substrates, 
we examined the activity of SETD6 with RelA pro-
tein (residues 1–431 [37, 38]). Previously, SETD6 was 
shown to methylate RelA on K310 leading to a dramatic 
modulation of NFκB transcriptional activity [38]. To 
measure SETD6 activity with RelA protein, we utilized 
RelA concentrations of up to 3  μM (Fig.  4a). Analysis 
of SETD6 activity at these RelA concentrations shows 
a linear increase in reaction rate with a slope of kcat/KM 
of 3.2·105  s−1 M−1 (Fig.  4b). These results demonstrate 
that our assay can be utilized to examine MTs activity 
with full length proteins as substrates, paving the way 
for additional studies to examine MTs activity with nat-
ural protein substrates. To further validate that the cou-
pling enzymes utilized in the MTs kinetic assay do not 
act as substrates for methylation, we utilized radioactive 
Fig. 3 Steady-state kinetics of SET7/9 methyl transfer activity to 
peptide derived from FoxO3 substrate. a Kinetic traces of SET7/9 at 
increased FoxO3 peptide concentrations (0–700 µM). Initial rates at 
each FoxO3 substrate concentration were calculated by fitting the 
raw data to a linear equation. Absorbance values at 340 nm in all 
reactions are normalized to 1 and the change in absorbance over 
time is presented as 1—the absorbance value obtains for each meas-
urement. b Michaelis–Menten (MM) plots for SET7/9 activity with 
FoxO3 peptide. The kinetic parameters derived from the fit to the MM 
equations are kcat of 32.1 ± 5.4 min−1 and KM of 165.4 ± 20.2 μM
Fig. 4 Steady-state kinetic analysis of SETD6 activity with RelA 
protein (residues 1–431). a Kinetic traces of SETD6 at increased RelA 
concentrations of 0–2.5 μM. Initial rate at each RelA concentration 
was calculated by fitting the raw data to a linear equation. Absorb-
ance values at 340 nm in all reactions are normalized to 1 and the 
change in absorbance over time is presented as 1—the absorbance 
value obtains for each measurement. b Fitting the initial rate data to 
linear equation allows the determination of kcat/KM to be 3.2·105 s−1 
M−1. Background reaction was subtracted from initial rates. c Radio-
active gel analysis of SETD6 activity with SAHN, ADE and RelA protein 
(1–431) showing that methylation does not take place on SAHN and 
ADE and only RelA is recognized as a substrate for SETD6
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[3H]-SAM as part of the SETD6 RelA coupled assay. The 
utilization of [3H]-SAM in the assay allows monitoring 
methylation of each protein in the reaction mixture using 
SDS-PAGE followed by autoradiography. We found that 
while RelA serves as a substrate for SETD6 [38], the SAH 
and ADE coupling enzymes do not and thus no signifi-
cant background is observed in the absence of substrate 
(Figs. 1, 4c).
Measurements of M.HaeIII methyl transfer activity 
with DNA substrate
To further examine the versatility of the assay for the 
general monitoring of MTs activity, we examined the 
methylation activity of M.HaeIII from Haemophilus 
aegyptius with DNA substrate. M.HaeIII belongs to a 
large family of bacterial DNA MTs that catalyses cyto-
sine C5 DNA methylation [39]. M.HaeIII methylates the 
internal cytosine of the canonical sequence GGCC and is 
utilized in the restriction-modification bacterial defense 
system against phage infection. To examine M.HaeIII 
activity using our coupled assay, we first prepared DNA 
substrate by PCR amplification of 1.6 kb DNA fragment 
from pGex plasmid containing six predicted methyla-
tion sites for M.HaeIII (Fig. 5a). We utilized the coupled 
assay to monitor M.HaeIII activity with different DNA 
concentrations and measured the initial reaction rates. 
We observed an increase in the initial rate of M.HaeIII 
catalysed DNA methylation at increased DNA substrate 
concentrations, demonstrating our ability to measure 
the kinetics of MTs with DNA substrates (Fig.  5b). To 
verify that M.HaeIII methylates DNA under the coupled 
assay conditions, we performed NotI digestion analy-
sis. Our DNA substrate contains one NotI cleavage site 
(GCGGC*CGC) that is located 1  kb from the 5′ of the 
DNA. Methylation of this site will prevent NotI cleav-
age leading to intact 1.6  kb substrate even in the pres-
ence of NotI. Indeed, we found that methylation of the 
DNA substrate by M.HaeIII in the presence of all cou-
pled assay components prevents NotI cleavage leading 
to the presence of undigested 1.6 kb fragment (Fig. 5c). 
These results highlight the utility of the coupled assay 
to efficiently monitor MTs activity with DNA substrates 
paving the way for quantitative analysis of many DNA 
methylation enzymes and sites.
Discussion
In the past decade, MTs have attracted significant atten-
tion due to their roles in regulating central biological pro-
cesses and their association with diseases [1–4]. Despite 
extensive investigations of the cellular roles of MTs, 
much less is known about their biochemical functions, 
substrate recognition and catalytic mechanism. The 
establishment of biochemical assay to readily monitor 
MTs activity will greatly facilitate such mechanistic 
research. Previously, several groups have attempted to 
establish biochemical assays for monitoring MTs activity; 
however, each approach suffers for different draw backs 
(see “Background” section).
Fig. 5 Monitoring DNA methyl transferase activity using the coupled 
kinetic assay. Steady-state kinetics of M.HaeIII methyl transfer activity 
with DNA fragment containing six methylation sites. a Scheme of 
DNA substrate for M.HaeIII containing six methylation sites (red) 
including one methylation site that is located at NotI recognition 
sequence. NotI cleavage at this site leads to two fragments of 550 and 
1050 bp. b Kinetic traces of M.HaeIII at increased M.HaeIII concentra-
tions (blue 1.5 μM, orange 3 μM and grey 6 μM) showing the increase 
in methylation rate. DNA concentration for all reactions was 400 nM. 
c DNA methylation by M.HaeIII prevents cleavage by NotI. Gel elec-
trophoresis analysis of the DNA substrate cleavage by NotI prior and 
following methylation by M.HaeIII. Methylation of the DNA substrate 
by M.HaeIII was performed in the M.HaeIII optimal reaction buffer and 
in the coupled assay buffer to ensure that the later does not interfere 
with DNA methylation (reaction time 3 h, M.HaeIII concentration is 
2 μM)
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Our assay is based on monitoring SAH formation by 
three-enzyme coupled reaction leading to the formation 
of ammonia and the oxidation of NADPH. Utilization of 
the different enzymes raises the concern that the enzyme 
used for the coupled reactions can serve as substrates for 
MTs. Utilizing a radioactive assay, we have shown that 
SETD6 does not methylate any of the coupling enzymes 
(Fig. 4c). Previously, the coupling of ammonia formation 
with α-ketoglutarate activity and NADPH oxidation was 
utilized for the establishment of Sirt1 deacetylase activity 
[40, 41]. In addition, the coupling of enzymatic transfer 
reactions to NADPH oxidation was extensively utilized 
for the detection of a wide range of glycosyltransferases 
for the quantitative determination of their catalytic 
activities [42]. To monitor glycosyltransferase activity, 
dinucleotides (e.g., UDP, or GDP) generated following 
sugar transfer activity are coupled to NADH oxidation by 
pyruvate kinase and lactate dehydrogenase [42, 43]. Thus, 
coupling different enzymatic reactions to glutamate 
dehydrogenase activity, enabling monitoring these reac-
tions at 340 nm, is a common tool for enzymatic activity 
determination.
Our coupled assay allows the continuous monitoring 
of MTs activity (Fig.  1). We believe that this assay can 
be used as a fast, convenient and inexpensive approach 
for the detailed biochemical characterization of a wide 
variety of MTs. Since the assay can be performed in a 
multi-well plate format, it can be readily adapted for 
high-throughput screening of MTs activity. Such screen-
ing can be highly useful in the search for new MTs inhibi-
tors or activators. Since the coupling of three enzymes is 
required to monitor MTs activity, appropriate controls 
must be taken to ensure the specificity of the new inhibi-
tors to the target methyltransferase.
Conclusion
In conclusion, we have developed a rapid, continuous 
three-enzyme coupled UV absorption assay for the char-
acterization of enzymes that use SAM to catalyze methyl 
transfer reactions. We have shown the versatility and 
robustness of this assay in monitoring the activity of two 
different protein methyl transferases SET7/9 and SETD6 
utilizing peptide and protein substrates, respectively. In 
addition, we showed that the coupled assay can be uti-
lized for monitoring DNA methylation kinetics using 
M.HaeIII as a model enzyme.
Methods
Molecular biology
SET7/9 gene was cloned into pET-Duet plasmid for E. 
coli expression and purification. The SET7/9 gene was 
PCR amplified from pGex-6p1 plasmid containing the 
gene as a template. The amplified DNA fragment was 
then cleaved by SpeI and XhoI restriction enzymes and 
ligated into a pET-Duet plasmid containing a malt-
ose binding domain (MBP) tag. The adenine deaminase 
(ADE, E.C. 3.5.4.4) and S-adenosyl-l-homocysteine 
nucleosidase (SAHN, E.C. 3.2.2.9) genes were amplified 
from the genomic DNA of an XL1 blue E. Coli strain 
using PCR. The amplified DNA fragments were then 
cleaved using NheI and HindIII restriction enzymes and 
ligated into a pET28a plasmid containing a Hisx6 tag at 
the N-terminal of the protein.
Protein expression and purification
SET7/9 enzyme was expressed from a pET-Duet plas-
mid containing the SET7/9 gene fused to a MBP tag in E. 
Coli BL21 (DE3). Expression was induced using 0.5 mM 
isopropyl b-d-1-thiogalactopyranoside (IPTG) for 6 h at 
30  °C. Following inductions, cells were centrifuged and 
resuspended at a buffer containing 25  mM Tris–HCL 
(pH 7.5), 200 mM NaCl and 1 mM DTT. The cells were 
lysed using a French press and the resulting cell extract 
was centrifuged at 13,000g for 1  h. The SET7/9 protein 
was then purified from the clear lysate using amylose 
beads (Amersham) according to standard procedures. 
The MBP tag was then cleaved using TEV protease for 
4 h at 4 °C and purified using gel-filtration chromatogra-
phy to obtain a monomeric SET7/9 protein. GST-SETD6 
was expressed and purified as previously described [38].
The RelA protein (residues 1–431) was expressed using 
a pGEX-6p1 plasmid containing the RelA gene fused to a 
GST tag in E. Coli BL21 (DE3). Expression was induced 
with 0.5  mM IPTG for 16  h at 20  °C. Following induc-
tions, cells were centrifuged and resuspended in buffer 
containing 25  mM Tris–HCL (pH 7.5), 200  mM NaCl 
and 1  mM DTT. The cells were lysed using a French 
press and the cell extract was centrifuged at 13,000g for 
1 h. The RelA protein was then purified using glutathione 
beads (Amersham) according to standard procedures.
The ADE enzyme was expressed from pET28a plas-
mid containing the ADE gene fused to a 6xHis tag at the 
N-terminal in E.coli BL21 (DE3). Expression was induced 
with 0.5  mM IPTG for 16  h at 20  °C. To replace the 
Fe2+ metal at the ADE active site with Mn2+, 50  μM of 
2,2′-dipyridyl and 1.0 mM MnCl2 were added at time of 
the induction [44]. Following induction, cells were cen-
trifuged and resuspended at a buffer containing 25 mM 
Tris–HCL (pH 7.5), 200 mM NaCl and 1 mM DTT. The 
cells were lysed using French press and the cell extract 
was centrifuged at 13,000g for 1 h. The ADE protein was 
then purified using nickel-NTA beads using standard 
procedures. Following purification, a dialysis against the 
original buffer was performed to remove the imidazole. 
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The SAHN protein was purified using the same purifica-
tion protocol without the metal replacement procedure 
performed for the ADE purification. For DNA methyla-
tion assays, commercial M.HaeIII enzyme was purchased 
from NEB.
Methylation assays
The continuous coupled methylation assay was carried 
out with clear flat bottom 96 well plates, containing 
4.5 µM SAHN, 3 µM ADE, 2.62 units of glutamate dehy-
drogenase (Ammonia detection kit, Sigma), 300  µM 
SAM and a varying concentration of methyltrans-
ferase enzyme and methyl acceptor. A concentration 
of 300  µM SAM was used to ensure saturation of the 
methyl donor. A final volume of 250 µl was reached in 
the well using the ammonia assay kit buffer (Sigma). 
The assay was performed at 30 °C, and the reaction was 
monitored at 340  nm using Tecan Infinite M200 plate 
reader. Kinetic parameters were derived by fitting to 
Michaelis–Menten Vo = kcat[E]0[S]0/([S]0 + KM) model. 
The TAT and FoxO3 peptide substrate sequences are 
GISYGRKKRRQRRRP (residues 44–58) and RGRAAK-
KKAALQTA (residues 264–277), respectively (methyl-
ated lysine is in bold). For deriving kinetic parameters, 
three replicates of each substrate concentration were 
used. All reactions were performed at 30  °C and were 
measured for a period of 10  min up to 1  h (Figs.  2, 3, 
4, 5). The buffer for all enzymes is 25 mM Tris pH 7.5, 
200 mM NaCl and 1 mM DTT supplemented with the 
buffer from the ammonia detection kit for the gluta-
mate dehydrogenase activity (Sigma). As a substitution 
for the ammonia detection kit, we used a defined reac-
tion conditions including Tris 25  mM pH7.5, bovine 
serum albumin (BSA) 0.5  % (v/v), 300  mM SAM, 
α-ketoglutarate 5 mM, NADPH 0.5 mM, SAHN 5 µM, 
ADE 3.5 µM and 2.62 units of glutamate dehydrogenase 
(Additional file 1: Figure S5). The rate of methyl transfer 
was still higher utilizing the Sigma buffer for ammonia 
detection (Ammonia detection kit, Sigma).
Radioactive in vitro methylation assay
Assays were performed as previously described [38]. 
Briefly, recombinant proteins were incubated with 
recombinant SETD6, and 2  mCi 3H-SAM (Amersham 
Pharmacia Biotech Inc, Piscataway, NJ, USA) in meth-
ylation buffer [50 mM Tris–HCL (pH 8.0), 10 % glycerol, 
20  mM KCl, 5  mM MgCl2 and 1  mM PMSF] at 30  °C 
overnight. The reaction mixture was resolved by SDS-
PAGE, followed by either autoradiography or Coomassie 
blue stain.
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Additional file 1: Figure S1. Establishment of the continuous coupled 
assay for MTs using short peptide as a substrate a. The detection of MTs 
activity is dependent on all assay components. The reaction cannot 
be monitored in the absence of glutamate dehydrogenase (orange) 
or adenine deaminase (ADE, grey). Activity is measured only when all 
reaction components are present including the peptide substrate (TAT 
peptide as an example, blue). Figure S2. Methyltransferase activity is the 
rate-determining step of NADPH oxidation. Doubling the concentration 
of each component in the total methyltransferase reaction does not lead 
to increase in methylation rate (A) SET7/9 (5 μM) activity with TAT peptide 
(500 μM) at 3 μM (blue) or 6 μM (orange) of adenine deaminase (ADE), 
2.62 units (blue) or 5.24 units (orange) of glutamate dehydrogenase and 
4.5 μM (blue) or 9 μM (orange) of SAH nucleosidase. (B) ADE activity with 
3 μM (blue) or 6 μM (orange) of the enzyme at 150 μM concentration of 
adenine (C) Glutamate dehydrogenase activity with 2.62 units (blue) or 
5.24 units (orange) of the enzyme at 30 μM NH4
+ concentration. (D) SAH 
nucleosidase activity 4.5 μM (blue) or 9 μM (orange) with 100 μM SAH 
concentration. Figure S3. Monitoring of SAHN activity at limiting SAH 
(Sigma) concentrations using the coupled assay. Activity was detected 
using SAHN 5 µM, ADE 3.5 µM and 2.62 units of glutamate dehydroge-
nase in the presence of 300 µM SAM by monitoring changes at 340 nm. 
Figure S4. Raw measurement of MT activity coupled with NADPH 
oxidation. A. The rate of absorbance decrease at 340 nm reflects the rate 
of SET7/9 activity with the TAT peptide (see also Figure S1 and Figure 2 
main paper). B. Absolute absorbance values are transformed to change in 
absorbance at 340 nm and the values of 1-absorbance change are shown 
to highlight the rate of methylation. Figure S5. SET7/9 activity with differ-
ent FoxO3 peptide concentrations in a defined reaction conditions includ-
ing Tris 25 mM pH 7.5, bovine serum albumin (BSA) 0.5 % (v/v), 300 mM 
SAM, α-ketoglutarate 5 mM, NADPH 0.5 mM, SAHN 5 µM, ADE 3.5 µM and 
2.62 units of glutamate dehydrogenase. Activity increases at increased 
peptide concentration.
Page 9 of 9Duchin et al. Epigenetics & Chromatin  (2015) 8:56 
References
 1. Dong C, Wu Y, Yao J, Wang Y, Yu Y, Rychahou PG, Evers BM, Zhou BP. G9a 
interacts with Snail and is critical for Snail-mediated E-cadherin repres-
sion in human breast cancer. J Clin Invest. 2012;122:1469–86.
 2. Islam AB, Richter WF, Jacobs LA, Lopez-Bigas N, Benevolenskaya EV. 
Co-regulation of histone-modifying enzymes in cancer. PLoS One. 
2011;6:e24023.
 3. Neff T, Sinha AU, Kluk MJ, Zhu N, Khattab MH, Stein L, Xie H, Orkin SH, 
Armstrong SA. Polycomb repressive complex 2 is required for MLL-AF9 
leukemia. Proc Natl Acad Sci USA. 2012;109:5028–33.
 4. Seligson DB, Horvath S, McBrian MA, Mah V, Yu H, Tze S, Wang Q, Chia D, 
Goodglick L, Kurdistani SK. Global levels of histone modifications predict 
prognosis in different cancers. Am J Pathol. 2009;174:1619–28.
 5. Del Rizzo PA, Trievel RC. Substrate and product specificities of SET domain 
methyltransferases. Epigenetics. 2011;6:1059–67.
 6. Schapira M. Structural chemistry of human SET domain protein methyl-
transferases. Curr Chem Genomics. 2011;5:85–94.
 7. Cedar H, Bergman Y. Linking DNA methylation and histone modification: 
patterns and paradigms. Nat Rev Genet. 2009;10:295–304.
 8. Hermann A, Gowher H, Jeltsch A. Biochemistry and biology of mamma-
lian DNA methyltransferases. Cell Mol Life Sci. 2004;61:2571–87.
 9. Bergman Y, Cedar H. DNA methylation dynamics in health and disease. 
Nat Struct Mol Biol. 2013;20:274–81.
 10. Ceccaldi A, Rajavelu A, Ragozin S, Senamaud-Beaufort C, Bashtrykov P, 
Testa N, Dali-Ali H, Maulay-Bailly C, Amand S, Guianvarc’h D, Jeltsch A, 
Arimondo PB. Identification of novel inhibitors of DNA methylation by 
screening of a chemical library. ACS Chem Biol. 2013;8:543–8.
 11. Luo M. Current chemical biology approaches to interrogate protein 
methyltransferases. ACS Chem Biol. 2012;7:443–63.
 12. Patnaik D, Chin HG, Esteve PO, Benner J, Jacobsen SE, Pradhan S. Sub-
strate specificity and kinetic mechanism of mammalian G9a histone H3 
methyltransferase. J Biol Chem. 2004;279:53248–58.
 13. Gowher H, Zhang X, Cheng X, Jeltsch A. Avidin plate assay system for 
enzymatic characterization of a histone lysine methyltransferase. Anal 
Biochem. 2005;342:287–91.
 14. Rathert P, Cheng X, Jeltsch A. Continuous enzymatic assay for histone 
lysine methyltransferases. Biotechniques. 2007;43:602–6.
 15. Dhayalan A, Dimitrova E, Rathert P, Jeltsch A. A continuous protein meth-
yltransferase (G9a) assay for enzyme activity measurement and inhibitor 
screening. J Biomol Screen. 2009;14:1129–33.
 16. Suh-Lailam BB, Hevel JM. A fast and efficient method for quantitative 
measurement of S-adenosyl-l-methionine-dependent methyltransferase 
activity with protein substrates. Anal Biochem. 2010;398:218–24.
 17. Florea M, Kudithipudi S, Rei A, Gonzalez-Alvarez MJ, Jeltsch A, Nau WM. 
A fluorescence-based supramolecular tandem assay for monitoring 
lysine methyltransferase activity in homogeneous solution. Chemistry. 
2012;18:3521–8.
 18. Kudithipudi S, Kusevic D, Jeltsch A. Non-radioactive protein lysine methyl-
transferase microplate assay based on reading domains. ChemMedChem. 
2014;9:554–9.
 19. Moore KE, Carlson SM, Camp ND, Cheung P, James RG, Chua KF, Wolf-Yad-
lin A, Gozani O. A general molecular affinity strategy for global detection 
and proteomic analysis of lysine methylation. Mol Cell. 2013;50:444–56.
 20. Carlson SM, Moore KE, Green EM, Martin GM, Gozani O. Proteome-wide 
enrichment of proteins modified by lysine methylation. Nat Protoc. 
2014;9:37–50.
 21. Klink TA, Staeben M, Twesten K, Kopp AL, Kumar M, Dunn RS, Pinchard CA, 
Kleman-Leyer KM, Klumpp M, Lowery RG. Development and validation 
of a generic fluorescent methyltransferase activity assay based on the 
transcreener AMP/GMP assay. J Biomol Screen. 2012;17:59–70.
 22. Machleidt T, Robers MB, Hermanson SB, Dudek JM, Bi K. TR-FRET cellular 
assays for interrogating posttranslational modifications of histone H3. J 
Biomol Screen. 2011;16:1236–46.
 23. Quinn AM, Allali-Hassani A, Vedadi M, Simeonov A. A chemilumines-
cence-based method for identification of histone lysine methyltrans-
ferase inhibitors. Mol Biosyst. 2010;6:782–8.
 24. Dorgan KM, Wooderchak WL, Wynn DP, Karschner EL, Alfaro JF, Cui Y, Zhou 
ZS, Hevel JM. An enzyme-coupled continuous spectrophotometric assay 
for S-adenosylmethionine-dependent methyltransferases. Anal Biochem. 
2006;350:249–55.
 25. Ibanez G, McBean JL, Astudillo YM, Luo M. An enzyme-coupled ultrasen-
sitive luminescence assay for protein methyltransferases. Anal Biochem. 
2010;401:203–10.
 26. Schaberle TF, Siba C, Hover T, Konig GM. An easy-to-perform photomet-
ric assay for methyltransferase activity measurements. Anal Biochem. 
2013;432:38–40.
 27. Cannon LM, Butler FN, Wan W, Zhou ZS. A stereospecific colorimetric 
assay for (S, S)-adenosylmethionine quantification based on thiopu-
rine methyltransferase-catalyzed thiol methylation. Anal Biochem. 
2002;308:358–63.
 28. Hendricks CL, Ross JR, Pichersky E, Noel JP, Zhou ZS. An enzyme-coupled 
colorimetric assay for S-adenosylmethionine-dependent methyltrans-
ferases. Anal Biochem. 2004;326:100–5.
 29. Collazo E, Couture JF, Bulfer S, Trievel RC. A coupled fluorescent assay for 
histone methyltransferases. Anal Biochem. 2005;342:86–92.
 30. Cornell KA, Riscoe MK. Cloning and expression of Escherichia coli 
5′-methylthioadenosine/S-adenosylhomocysteine nucleosidase: identifi-
cation of the pfs gene product. Biochim Biophys Acta. 1998;1396:8–14.
 31. Humphries BA, Melnychuk M, Donegan EJ, Snee RD. Automated enzy-
matic assay for plasma ammonia. Clin Chem. 1979;25:26–30.
 32. Pradhan S, Chin HG, Esteve PO, Jacobsen SE. SET7/9 mediated 
methylation of non-histone proteins in mammalian cells. Epigenetics. 
2009;4:383–7.
 33. Kouskouti A, Scheer E, Staub A, Tora L, Talianidis I. Gene-specific 
modulation of TAF10 function by SET9-mediated methylation. Mol Cell. 
2004;14:175–82.
 34. Wilson JR, Jing C, Walker PA, Martin SR, Howell SA, Blackburn GM, Gam-
blin SJ, Xiao B. Crystal structure and functional analysis of the histone 
methyltransferase SET7/9. Cell. 2002;111:105–15.
 35. Calnan DR, Webb AE, White JL, Stowe TR, Goswami T, Shi X, Espejo A, 
Bedford MT, Gozani O, Gygi SP, Brunet A. Methylation by Set9 modu-
lates FoxO3 stability and transcriptional activity. Aging (Albany NY). 
2012;4:462–79.
 36. Esteve PO, Chin HG, Benner J, Feehery GR, Samaranayake M, Horwitz GA, 
Jacobsen SE, Pradhan S. Regulation of DNMT1 stability through SET7-
mediated lysine methylation in mammalian cells. Proc Natl Acad Sci U S 
A. 2009;106:5076–81.
 37. Chang Y, Levy D, Horton JR, Peng J, Zhang X, Gozani O, Cheng X. 
Structural basis of SETD6-mediated regulation of the NF-κB network via 
methyl-lysine signaling. Nucleic Acids Res. 2011;39:6380–9.
 38. Levy D, Kuo AJ, Chang Y, Schaefer U, Kitson C, Cheung P, Espejo A, Zee BM, 
Liu CL, Tangsombatvisit S, Tennen RI, Kuo AY, Tanjing S, Cheung R, Chua 
KF, Utz PJ, Shi X, Prinjha RK, Lee K, Garcia BA, Bedford MT, Tarakhovsky A, 
Cheng X, Gozani O. Lysine methylation of the NF-kappaB subunit RelA by 
SETD6 couples activity of the histone methyltransferase GLP at chromatin 
to tonic repression of NF-κB signaling. Nat Immunol. 2011;12:29–36.
 39. Kumar S, Cheng X, Klimasauskas S, Mi S, Posfai J, Roberts RJ, Wilson 
GG. The DNA (cytosine-5) methyltransferases. Nucleic Acids Res. 
1994;22:1–10.
 40. Meledin R, Brik A, Aharoni A. Dissecting the roles of the N- and C-flanking 
residues of acetyllysine substrates for SIRT1 activity. Chembiochem. 
2013;14:577–81.
 41. Smith BC, Hallows WC, Denu JM. A continuous microplate assay 
for sirtuins and nicotinamide-producing enzymes. Anal Biochem. 
2009;394:101–9.
 42. Gosselin S, Alhussaini M, Streiff MB, Takabayashi K, Palcic MM. A continu-
ous spectrophotometric assay for glycosyltransferases. Anal Biochem. 
1994;220:92–7.
 43. Aharoni A, Thieme K, Chiu CPC, Buchini S, Lairson LL, Chen H, Strynadka 
NCJ, Wakarchuk WW, Withers SG. High-throughput screening method-
ology for the directed evolution of glycosyltransferases. Nat Methods. 
2006;3:609–14.
 44. Kamat SS, Bagaria A, Kumaran D, Holmes-Hampton GP, Fan H, Sali A, 
Sauder JM, Burley SK, Lindahl PA, Swaminathan S, Raushel FM. Catalytic 
mechanism and three-dimensional structure of adenine deaminase. 
Biochemistry. 2011;50:1917–27.
